La maladie de Parkinson au Canada (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Models, Biological »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Models, Animal < Models, Biological < Models, Cardiovascular  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]
Ident.Authors (with country if any)Title
000154 (2001) C J Sinclair [Canada] ; L. Krizanac-Bengez ; K A Stanness ; D. Janigro ; F E ParkinsonAdenosine permeation of a dynamic in vitro blood-brain barrier inhibited by dipyridamole.
000172 (2001) S K Patrick [Canada] ; A A Denington ; M J Gauthier ; D M Gillard ; A. ProchazkaQuantification of the UPDRS Rigidity Scale.
000190 (2001) R. De La Fuente-Fernández [Canada] ; A S Lim ; V. Sossi ; J E Holden ; D B Calne ; T J Ruth ; A J StoesslApomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.
000201 (2002) Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández ; James E. Holden ; Doris J. Doudet ; Jess Mckenzie ; A J Stoessl ; T J RuthIncrease in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.
000319 (2003) Fiona E. Parkinson [Canada] ; Jessica Friesen ; Ljiljana Krizanac-Bengez ; Damir JanigroUse of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain.
000406 (2004) S M Hashemi [Canada] ; M F Golnaraghi ; A E PatlaTuned vibration absorber for suppression of rest tremor in Parkinson's disease.
000436 (2004) John T. Brosnan [Canada] ; Rene L. Jacobs ; Lori M. Stead ; Margaret E. BrosnanMethylation demand: a key determinant of homocysteine metabolism.
000437 (2004) Hyman M. Schipper [Canada]Brain iron deposition and the free radical-mitochondrial theory of ageing.
000456 (2004) Ronald B. Postuma [Canada] ; Anthony E. LangHomocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
000495 (1992) D. Parkinson [Canada]Concussion is completely reversible; an hypothesis.
000528 (2005) Fiona E. Parkinson [Canada] ; Wei Xiong ; Christina R. ZamzowAstrocytes and neurons: different roles in regulating adenosine levels.
000571 (2005) Robert J. Parkinson [Canada] ; Jennifer L. Durkin ; Jack P. CallaghanEstimating the compressive strength of the porcine cervical spine: an examination of the utility of DXA.
000589 (1992) M P Rathbone [Canada] ; S. Deforge ; B. Deluca ; B. Gabel ; C. Laurenssen ; P. Middlemiss ; S. ParkinsonPurinergic stimulation of cell division and differentiation: mechanisms and pharmacological implications.
000620 (2006) J D Schulz [Canada] ; E L Hawkes ; C A ShawCycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator.
000626 (2006) Christina R. Zamzow [Canada] ; Ratna Bose ; Fiona E. ParkinsonThe effect of acidosis on adenosine release from cultured rat forebrain neurons.
000697 (2006) Chris Sanford [Canada] ; Matthew L K. Yip ; Carl White ; John ParkinsonCell++--simulating biochemical pathways.
000840 (2007) Hossein Aleyasin [Canada] ; Maxime W. C. Rousseaux [Canada] ; Maryam Phillips [Canada] ; Raymond H. Kim [Canada] ; Ross J. Bland [États-Unis] ; Steve Callaghan [Canada] ; Ruth S. Slack [Canada] ; Matthew J. During [États-Unis] ; Tak W. Mak [Canada] ; David S. Park [Canada]The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage
000843 (????) Frédéric Calon [Canada] ; Greg ColeNeuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies.
000919 (2008) J R Post [Canada] ; L. Persson ; E A Parkinson ; T. Van KootenAngler numerical response across landscapes and the collapse of freshwater fisheries.
000950 (2009) S J Palmer [Canada] ; L. Eigenraam ; T. Hoque ; R G Mccaig ; A. Troiano ; M J MckeownLevodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
000966 (2008) Susan H. Fox [Canada] ; Jonathan M. Brotchie ; Anthony E. LangNon-dopaminergic treatments in development for Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Models, Biological" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Models, Biological" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Models, Biological
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022